# name
Pathways to ensure universal and affordable access to hepatitis
                C treatment

# metadata.dc.description.abstract[].value
Direct-acting antivirals (DAAs) have dramatically changed
                the landscape of hepatitis C treatment and prevention. The World
                Health Organization has called for the elimination of hepatitis
                C as a public health threat by 2030. However, the discrepancy in
                DAA prices across low-, middle- and high-income countries is
                considerable, ranging from less than US$ 100 to approximately
                US$ 40,000 per course, thus representing a major barrier for the
                scale-up of treatment and elimination. This article describes
                DAA pricing and pathways to accessing affordable treatment,
                providing case studies from Australia, Egypt and Portugal.
                Pathways to accessing DAAs include developing comprehensive
                viral hepatitis plans to facilitate price negotiations,
                voluntary and compulsory licenses, patent opposition, joint
                procurement, and personal importation schemes. While multiple
                factors influence the price of DAAs, a key driver is a country's
                capacity and willingness to negotiate with pharmaceutical
                companies. If negotiations do not lead to a reasonable price,
                governments have the option to utilise flexibilities outlined in
                the Agreement on Trade-Related Aspects of Intellectual Property
                Rights. Affordable access to DAAs is underpinned by
                collaboration between government, civil society, global
                organisations and pharmaceutical companies to ensure that all
                patients can access treatment. Promoting these pathways is
                critical for influencing policy, improving access to affordable
                DAAs and achieving hepatitis C elimination.

# metadata.dc.relation.isformatof[].value
Reproducció del document publicat a: http://dx.doi.org/
                10.1186/s12916-018-1162-z

# metadata.dc.source[].value
Articles publicats en revistes (ISGlobal)

# metadata.dc.title[].value
Pathways to ensure universal and affordable access to hepatitis
                C treatment